Premaitha’s non-invasive prenatal test available on the NHS (UK)
Premaitha Health has gotten UK’s Department of Health approval to make non-invasive prenatal tests (“NIPT”)
Pharmaceuticals, Biotechnology and Life Sciences
Premaitha Health has gotten UK’s Department of Health approval to make non-invasive prenatal tests (“NIPT”)
Sanofi and Regeneron Pharmaceuticals have announced the FDA issued a Complete Response Letter (CRL) regarding…
Finish patent office has accepts Faron’s new formulation for a respiratory orphan disease ARDS
Advanced Oncotherapy has named Nicolas Serandour the new CEO…
AstraZeneca’s Lynparza tablets against BRCA-mutated ovarian cancer have shown…
Faron Pharmaceuticals (Faron), the clinical stage biopharmaceutical company, has recruited the first patient in the Japanese Phase III pivotal clinical trial for the…
Esperite`s business unit The Cell Factory in collaboration with Women`s and Children`s Health Department of the University of Padua and the Padua University Hospital are developing therapies for inflammatory bowel disease (IBD) using extracellular vesicles (EVs).
Transgene, a company focused on designing and developing targeted immunotherapies for the treatment of cancer and infectious diseases, announced the launch and terms of a share capital increase with shareholders’ preferential subscription rights for a total gross amount of circa €48 million, issue premium included (the “Rights Issue”).
Genomic Vision, DNA molecular combing specialist that develops tests for the diagnostics market and tools for the life sciences research market, has presented, at the Annual Meeting of the American Society of Human Genetics, the initial results of the pilot study undertaken with Quest Diagnostics that aims to identify a biomarker to improve genetic counseling for Spinal Muscular Atrophy (SMA) in the African-American population.